Healthcare provider profile · identity verified

Michael David Reiner, M.D.

Allopathic & Osteopathic Physicians|Internal Medicine · PAHRUMP, NV · NPI 1285698381

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Michael David Reiner, M.D. received $108.40 in general payments during 2025 across 6 reported records.

Dexcom, Inc. accounted for 50.9% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 49 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Trulicity by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$108.40

6 reported records · 4 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Dexcom, Inc.	Unresolved — no canonical attribution shown	$55.19	50.9%	3	2025
Axsome Therapeutics, Inc.	Unresolved — no canonical attribution shown	$18.64	17.2%	1	2025
Lilly USA, LLC	Unresolved — no canonical attribution shown	$18.39	17.0%	1	2025
Exact Sciences Corporation	Unresolved — no canonical attribution shown	$16.18	14.9%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$108.40	6

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Dexcom G6 Transmitter Normalized: dexcom g6 transmitter	Medical Supply	Dexcom, Inc.	$55.19	3	2025
Source payment records 2025-06-05 · Dexcom, Inc. · $13.49 · Open Payments source 2025-10-09 · Dexcom, Inc. · $21.70 · Open Payments source 2025-12-04 · Dexcom, Inc. · $20.00 · Open Payments source
Auvelity Normalized: auvelity	Drug	Axsome Therapeutics, Inc.	$18.64	1	2025
Source payment records 2025-08-06 · Axsome Therapeutics, Inc. · $18.64 · Open Payments source
MOUNJARO Normalized: mounjaro	Drug	Lilly USA, LLC	$18.39	1	2025
Source payment records 2025-09-09 · Lilly USA, LLC · $18.39 · Open Payments source
ZEPBOUND Normalized: zepbound	Drug	Lilly USA, LLC	$18.39	1	2025
Source payment records 2025-09-09 · Lilly USA, LLC · $18.39 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	49	16
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	23	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	884	276
Rosuvastatin Calcium	Rosuvastatin Calcium	873	290
Amlodipine Besylate	Amlodipine Besylate	688	216
Losartan Potassium	Losartan Potassium	614	193
Levothyroxine Sodium	Levothyroxine Sodium	577	183
Lisinopril	Lisinopril	522	165
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	485	64
Ezetimibe	Ezetimibe	441	147
Omeprazole	Omeprazole	344	121
Metformin Hcl	Metformin Hcl	316	101
Gabapentin	Gabapentin	309	104
Hydrochlorothiazide	Hydrochlorothiazide	294	95
Tamsulosin Hcl	Tamsulosin Hcl	284	96
Metoprolol Tartrate	Metoprolol Tartrate	271	94
Alprazolam	Alprazolam	259	41
Oxycodone Hcl	Oxycodone Hcl	255	32
Pantoprazole Sodium	Pantoprazole Sodium	248	81
Hydromorphone Hcl	Hydromorphone Hcl	212	33
Albuterol Sulfate Hfa	Albuterol Sulfate	208	81
Folic Acid	Folic Acid	203	63
Famotidine	Famotidine	201	72
Clopidogrel	Clopidogrel Bisulfate	195	59
Furosemide	Furosemide	195	58
Simvastatin	Simvastatin	194	63
Morphine Sulfate Er	Morphine Sulfate	188	16
Montelukast Sodium	Montelukast Sodium	187	63
Pravastatin Sodium	Pravastatin Sodium	174	51
Potassium Chloride	Potassium Chloride	171	58
Metoprolol Succinate	Metoprolol Succinate	163	48
Diazepam	Diazepam	159	26
Tramadol Hcl	Tramadol Hcl	153	35
Trazodone Hcl	Trazodone Hcl	149	40
Sertraline Hcl	Sertraline Hcl	142	45
Alendronate Sodium	Alendronate Sodium	131	40
Finasteride	Finasteride	131	43
Lorazepam	Lorazepam	125	26
Eliquis	Apixaban	123	39
Carvedilol	Carvedilol	118	42
Memantine Hcl	Memantine Hcl	118	39
Methadone Hcl	Methadone Hcl	118	suppressed
Pregabalin	Pregabalin	115	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	114	31
Meloxicam	Meloxicam	109	33
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	109	15
Duloxetine Hcl	Duloxetine Hcl	105	31
Ropinirole Hcl	Ropinirole Hcl	104	28
Atenolol	Atenolol	101	30
Olmesartan Medoxomil	Olmesartan Medoxomil	93	29
Allopurinol	Allopurinol	90	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	88	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	86	25
Liothyronine Sodium	Liothyronine Sodium	85	29
Fluticasone Propionate	Fluticasone Propionate	78	26
Zolpidem Tartrate	Zolpidem Tartrate	77	14
Spironolactone	Spironolactone	76	28
Ondansetron Odt	Ondansetron	69	25
Fluoxetine Hcl	Fluoxetine Hcl	68	23
Diclofenac Sodium	Diclofenac Sodium	64	29
Tizanidine Hcl	Tizanidine Hcl	62	26
Xarelto	Rivaroxaban	61	15
Glipizide	Glipizide	59	21
Baclofen	Baclofen	56	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	55	16
Anastrozole	Anastrozole	54	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	53	14
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	52	11
Warfarin Sodium	Warfarin Sodium	51	13
Jardiance	Empagliflozin	49	16
Amitriptyline Hcl	Amitriptyline Hcl	48	14
Escitalopram Oxalate	Escitalopram Oxalate	47	15
Amiodarone Hcl	Amiodarone Hcl	45	19
Benazepril Hcl	Benazepril Hcl	45	13
Citalopram Hbr	Citalopram Hydrobromide	45	16
Buspirone Hcl	Buspirone Hcl	44	15
Ibuprofen	Ibuprofen	44	20
Humalog Kwikpen U-100	Insulin Lispro	43	21
Clonidine Hcl	Clonidine Hcl	41	13
Ipratropium Bromide	Ipratropium Bromide	41	12
Metformin Hcl Er	Metformin Hcl	41	18
Ozempic	Semaglutide	41	14
Rybelsus	Semaglutide	41	13
Nebivolol Hcl	Nebivolol Hcl	40	12
Nitroglycerin	Nitroglycerin	39	13
Ketoconazole	Ketoconazole	38	19
Levetiracetam	Levetiracetam	38	11
Digoxin	Digoxin	37	12
Oxybutynin Chloride Er	Oxybutynin Chloride	37	11
Levofloxacin	Levofloxacin	36	29
Testosterone Cypionate	Testosterone Cypionate	36	suppressed
Gemfibrozil	Gemfibrozil	35	suppressed
Fenofibrate	Fenofibrate	34	11
Glipizide Er	Glipizide	34	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	23
Celecoxib	Celecoxib	33	12
Hydroxyzine Hcl	Hydroxyzine Hcl	33	13
Primidone	Primidone	33	suppressed
Valsartan	Valsartan	33	11
Methotrexate	Methotrexate Sodium	32	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	26
Oxybutynin Chloride	Oxybutynin Chloride	30	12
Sildenafil Citrate	Sildenafil Citrate	30	12
Sucralfate	Sucralfate	30	15
Amoxicillin	Amoxicillin	29	17
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	29	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	29	11
Acyclovir	Acyclovir	28	16
Donepezil Hcl	Donepezil Hcl	28	suppressed
Farxiga	Dapagliflozin Propanediol	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	12
Nifedipine Er	Nifedipine	28	suppressed
Estradiol	Estradiol	27	suppressed
Morphine Sulfate	Morphine Sulfate	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Naproxen	Naproxen	26	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Prednisone	Prednisone	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Irbesartan	Irbesartan	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	15
Trulicity	Dulaglutide	23	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	22	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	21	suppressed
Entresto	Sacubitril/Valsartan	21	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	21	suppressed
Probenecid	Probenecid	21	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	20	suppressed
Clonazepam	Clonazepam	20	suppressed
Latanoprost	Latanoprost	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	19	suppressed
Mometasone Furoate	Mometasone Furoate	19	11
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Topiramate	Topiramate	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Methylprednisolone	Methylprednisolone	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Fluconazole	Fluconazole	14	11
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Imatinib Mesylate	Imatinib Mesylate	13	suppressed
Linzess	Linaclotide	13	suppressed
Penicillin V Potassium	Penicillin V Potassium	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Methimazole	Methimazole	12	suppressed
Temazepam	Temazepam	12	suppressed
Torsemide	Torsemide	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Misoprostol	Misoprostol	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Pentoxifylline	Pentoxifylline	11	suppressed
Ramipril	Ramipril	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$108.40 · 6 records	Dexcom, Inc.	Auvelity, Dexcom G6 Transmitter, MOUNJARO, ZEPBOUND	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error